Halozyme Therapeutics (HALO) Work In Process (2011 - 2026)
Halozyme Therapeutics (HALO) reported Work In Process of $39.4 million for Q2 2026, up 27.4% from $30.93 million a year earlier and up 12.4% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Work In Process (2011 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Work In Process of $30.92 million, up 2.5% from FY2024.
- Work In Process has a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- By year, Work In Process came in at $30.17 million in FY2024 (-11.3%), $34.03 million in FY2023 (-15.7%), $40.36 million in FY2022 (+131.3%) and $17.45 million in FY2021 (-48.3%).
- The Q2 2026 figure ranks as the highest quarterly Work In Process since Q1 2024.
- Year over year, Work In Process gained in three of the last eight quarters, with growth averaging 7.0%.
- The high point for year-over-year Work In Process in five years was Q1 2023 (growth of 332.8%); the low point was Q1 2022 (a decline of 67.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $35.04 million (Q1 2026), $30.92 million (Q4 2025) and $34.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 14.65 Bn | 13.25 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.40 Mn |
| Mar 31, 2026 | 35.04 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 34.84 Mn |
| Jun 30, 2025 | 30.93 Mn |
| Mar 31, 2025 | 36.65 Mn |
| Dec 31, 2024 | 30.17 Mn |
| Sep 30, 2024 | 14.89 Mn |
| Jun 30, 2024 | 36.69 Mn |
| Mar 31, 2024 | 43.61 Mn |
| Dec 31, 2023 | 34.03 Mn |
| Sep 30, 2023 | 37.57 Mn |
| Jun 30, 2023 | 50.34 Mn |
| Mar 31, 2023 | 27.40 Mn |
| Dec 31, 2022 | 40.36 Mn |
| Sep 30, 2022 | 56.25 Mn |
| Jun 30, 2022 | 44.17 Mn |
| Mar 31, 2022 | 6.33 Mn |
| Dec 31, 2021 | 17.45 Mn |
| Sep 30, 2021 | 21.72 Mn |
API Access
Halozyme Therapeutics Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();